Genetically engineered mouse models of brain cancer and the promise of preclinical testing Journal Article


Authors: Huse, J. T.; Holland, E. C.
Article Title: Genetically engineered mouse models of brain cancer and the promise of preclinical testing
Abstract: Recent improvements in the understanding of brain tumor biology have opened the door to a number of rational therapeutic strategies targeting distinct oncogenic pathways. The successful translation of such "designer drugs" to clinical application depends heavily on effective and expeditious screening methods in relevant disease models. By recapitulating both the underlying genetics and the characteristic tumor-stroma microenvironment of brain cancer, genetically engineered mouse models (GEMMs) may offer distinct advantages over cell culture and xenograft systems in the preclinical testing of promising therapies. This review focuses on recently developed GEMMs for both glioma and medulloblastoma, and discusses their potential use in preclinical trials. Examples showcasing the use of GEMMs in the testing of molecularly targeted therapeutics are given, and relevant topics, such as stem cell biology, in vivo imaging technology and radiotherapy, are also addressed. © 2008 The Authors.
Keywords: unclassified drug; nonhuman; conference paper; temozolomide; neuroimaging; glioma; brain neoplasms; antineoplastic agent; mouse; animals; mice; animal tissue; tumor xenograft; drug evaluation, preclinical; cancer model; carcinogenesis; transgenic mouse; mice, transgenic; temsirolimus; genetic engineering; medulloblastoma; cancer stem cell; vatalanib; oligodendroglioma; targeted therapy; brain cancer; microenvironment; disease models, animal; doxycycline; astrocytoma; clinical trials; murine model; hhantag; perifosine; technology
Journal Title: Brain Pathology
Volume: 19
Issue: 1
ISSN: 1015-6305
Publisher: Blackwell Publishing  
Date Published: 2009-01-01
Start Page: 132
End Page: 143
Language: English
DOI: 10.1111/j.1750-3639.2008.00234.x
PUBMED: 19076778
PROVIDER: scopus
PMCID: PMC2659383
DOI/URL:
Notes: --- - "Cited By (since 1996): 15" - "Export Date: 30 November 2010" - "CODEN: BRPAE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eric Holland
    225 Holland
  2. Jason T Huse
    143 Huse